Evidence map›Paper›PMID 41811588›Full record

ArticleProbiotics and antimicrobial proteins2026

Probiotic Supplementation with BLa80, BL21, and LRa05 Improves Gut Microbiota in Chronic Hepatitis B Patients Receiving Tenofovir Alafenamide: A Randomized, Double-Blind, Placebo-Controlled Trial.

Long Jianfei, Wang Li, Xiang Xi, Wei Lanyi, He Tianye, Wang Jinyu, Chi Xiangyu, Hu Tiantian, Jia Yidi, Li Ling and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Long Jianfei *Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. longjianfei@huashan.org.cn.
Wang Li *Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Xiang XiThe Faculty of Medicine, Qilu Institute of Technology, Jinan, 250200, China.
Wei LanyiDepartment of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
He TianyeDepartment of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.
Wang JinyuDepartment of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China.
Chi XiangyuDepartment of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China.
Hu TiantianDepartment of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China.
Jia YidiDepartment of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China.
Li LingDepartment of Pharmacy, Jing'an District Central Hospital, Fudan University, Shanghai, China.
Gao YuanDepartment of Pharmacy, Yichang Central People's Hospital, Hubei, China.
Zhu HaoxiangDepartment of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China. haoxiangzhu2015@163.com.
Zhang JimingDepartment of Infectious Diseases, Huashan Hospital, Fudan University, No.12 Middle Wu Lu Mu Qi Road, Shanghai, 200040, China. jmzhang@fudan.edu.cn.
Wang BinDepartment of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. wangbin@huashan.org.cn.

Funding

National Natural Science Foundation of China 82003864
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DysbiosisGut-liver axisMetabolic dysfunctionMicrobial therapeuticsViral hepatitis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.